What is the evidence supporting the use of SGLT2 inhibitors in preventing calcium-based renal calculi?
There is direct evidence supporting the use of SGLT2 inhibitors in reducing the risk of nephrolithiasis, including calcium-based stones, primarily driven by their physiological effects on urine composition and flow.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-11
- DOI
- https://doi.org/10.5281/zenodo.24122913
- Primary Topic
- Kidney Stones and Urolithiasis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00